News

The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...
A research team at the University of Osaka has unveiled the molecular mechanism behind genome ejection from adeno-associated ...
The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...
Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene ...
And other biotech news brought to you by The Readout.
We look at the continued turmoil within the FDA, including the forced dismissal of top gene therapy regulator Nicole Verdun, ...
The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about how gene therapies will be regulated under new FDA leadership.
Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them ...
Verve's top drug, Verve-102, is designed to target a gene called PCSK9, which is associated with heart health and cholesterol levels.
Gene therapy has proved to be a safe long-term treatment for haemophilia B. The benefits of a single dose persist for at ...
Ticker: Second patient death reported with gene therapy for muscular dystrophy; Salmonella poisoning linked to pistachio ...